Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' ECKLAND DJA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 13 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. YOUNG MA; ECKLAND DJA; EASTMOND R; LETTIS S
      ESTABLISHING THE DOSE-RESPONSE CURVE FOR METABOLIC CONTROL WITH TROGLITAZONE, AN INSULIN ACTION ENHANCER, IN TYPE-2 DIABETES PATIENTS

      Annals of medicine
    2. HOVORKA R; BANNISTER P; ECKLAND DJA; HALLIDAY D; MURLEY DN; REES SE; YOUNG MA
      REPRODUCIBILITY AND COMPARABILITY OF INSULIN SENSITIVITY INDEXES MEASURED BY STABLE-LABEL INTRAVENOUS GLUCOSE-TOLERANCE TEST

      Diabetic medicine
    3. HOVORKA R; ECKLAND DJA; HALLIDAY D; LETTIS S; ROBINSON CE; BANNISTER P; YOUNG MA; BYE A
      CONSTANT INFUSION AND BOLUS INJECTION OF STABLE-LABEL TRACER GIVE REPRODUCIBLE AND COMPARABLE FASTING HGO

      American journal of physiology: endocrinology and metabolism
    4. FOOT EA; LETTIS S; ECKLAND DJA
      EVIDENCE FOR TROGLITAZONE, A NOVEL ANTIDIABETIC AGENT, ACTING AS AN INSULIN ACTION ENHANCER

      Diabetologia
    5. ECKLAND DJA; FRITH L; STARKIE M; ALDERTON C
      TROGLITAZONE IMPROVES ALBUMINURIA TYPE-2 DIABETIC-PATIENTS

      Diabetologia
    6. YOUNG MA; STARKIE M; LETTIS S; ECKLAND DJA
      TROGLITAZONE ADDED TO A SULFONYLUREA SHOWS A DOSE-RESPONSE CONSISTENTWITH MONOTHERAPY

      Diabetologia
    7. FOOT EA; WILLIAMS ZV; MOHAMEDALI V; YUDKIN JS; ECKLAND DJA
      TROGLITAZONE BUT NOT GLIBENCLAMIDE REDUCES PROINSULIN-LIKE MOLECULES,RISK-FACTORS FOR CARDIOVASCULAR-DISEASE, IN NIDDM PATIENTS

      Diabetologia
    8. ECKLAND DJA; WILLIAMS ZV; FOOT EA
      TROGLITAZONE IMPROVES GLYCEMIA BUT DOES NOT INCREASE THE RISK OF HYPOGLYCEMIA FOLLOWING ALCOHOL IN DIET-TREATED NIDDM SUBJECTS

      Diabetologia
    9. ENTWISLE SJ; FOWLER PA; THOMAS M; ECKLAND DJA; LETTIS S; YORK M; FREEDMAN PS
      THE EFFECTS OF ORAL SUMATRIPTAN, A 5-HT1 RECEPTOR AGONIST, ON CIRCULATING ACTH AND CORTISOL CONCENTRATIONS IN MAN

      British journal of clinical pharmacology
    10. FOOT EA; PATEL J; WILLIAMS ZV; ECKLAND DJA
      IMPROVED METABOLIC CONTROL BY ADDITION OF TROGLITAZONE TO GLIBENCLAMIDE THERAPY IN NON-INSULIN-DEPENDENT DIABETICS

      Diabetologia
    11. HOVORKA R; PATEL J; WILLIAMS ZV; PIRJAMALI F; YOUNG MA; ECKLAND DJA
      REPRODUCIBILITY OF INSULIN SENSITIVITY INDEXES FROM STABLE-LABEL EUGLYCEMIC GLUCOSE CLAMP STUDIES

      Diabetologia
    12. CHOWDREY HS; LARSEN PJ; HARBUZ MS; JESSOP DS; AGUILERA G; ECKLAND DJA; LIGHTMAN SL
      EVIDENCE FOR ARGININE-VASOPRESSIN AS THE PRIMARY ACTIVATOR OF THE HPAAXIS DURING ADJUVANT-INDUCED ARTHRITIS

      British Journal of Pharmacology
    13. HOVORKA R; PATEL J; LETTIS S; PIRJAMALI R; YOUNG MA; ECKLAND DJA
      REPRODUCIBILITY OF PREHEPATIC INSULIN-SECRETION DURING IVGTT

      Diabetologia


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/01/21 alle ore 21:40:22